✉news TechnologyTechnology first seen 1 d ago, last 1 d ago, peak #14

Pet cloning, cryonics and longevity drugs: biotech's new market

Original: Pet cloning, cryonics and longevity drugs: biotech’s new market

Biotech companies are increasingly selling radical services once confined to science fiction, including pet cloning, cryonics and experimental longevity drugs. The industry is turning these frontier technologies into a commercial market, raising questions about cost, ethics and who can afford them.

Why now: Growing interest in life-extension and cloning services is pushing biotech into a controversial new consumer market.

biotech industrypet cloning companiescryonics providerslongevity drug developers

Open on news →

Evidence

• Pet cloning, cryonics and longevity drugs: biotech’s new market · The Next Web

API: https://socialmediatrends-api.osmike.com/v1/trends/2735947